2015-10: Expanded Natural Killer Cells and Elotuzumab for High-Risk Myeloma Post- Autologous Stem Cell Transplant (ASCT)
Clinical trial NCT03003728 · WITHDRAWN
Trial details
- NCT number
- NCT03003728
- Sponsor
- University of Arkansas
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-01
- Primary completion
- 2020-07-08
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.